Investments

Buyout
Held / Exited
  • Logo Seqens
    Buyout

    Seqens

    France

    Industrials

    Exited

    Industrials

    Sequens is a producer of essential chemicals for use in everyday products. The group is structured across 3 divisions: Pharmaceutical & Cosmetics, Performance Chemicals and Mineral Specialties. Seqens is an industry leader across a wide range of products including aspirin, paracetamol, salicylic acid, para-aminophenol, soda ash, sodium bicarbonate, phenol and oxygenated solvents. It targets a set of five resilient and diversified end-markets including pharma & healthcare, food & feed, cosmetics, flavors & fragrances, home care and environment. Seqens serves 750 customers from 14 industrial sites located in Europe and Asia, and employs ~1,600 people.

We appreciate Ardian’s unique support on our growth path that helped us very much to become market leader and position us ideally for future growth.”

Daniel Schustermann Managing Director of Schustermann & Borenstein

It is an efficient team, determined and confident in its choices, and always attentive to its partners. The relationships of trust that the Ardian team builds over time, with the management teams and, beyond that, with the advisors around them, are part of their DNA.

David Aknin Lawyer